evans blue has been researched along with cefotaxime in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Birngruber, T; Ghosh, A; Kroath, T; Perez-Yarza, V; Pieber, TR; Ratzer, M; Sinner, F | 1 |
2 other study(ies) available for evans blue and cefotaxime
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cerebral open flow microperfusion: a new in vivo technique for continuous measurement of substance transport across the intact blood-brain barrier.
Topics: Animals; Anti-Bacterial Agents; Biological Transport; Blood-Brain Barrier; Cefotaxime; Evans Blue; Fluorescein; Male; Microdialysis; Perfusion; Permeability; Rats; Rats, Sprague-Dawley | 2013 |